𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rituximab Maintenance Therapy After Autologous Stem-Cell Transplantation in Patients With Relapsed CD20+ Diffuse Large B-Cell Lymphoma: Final Analysis of the Collaborative Trial in Relapsed Aggressive Lymphoma

✍ Scribed by Gisselbrecht, C.; Schmitz, N.; Mounier, N.; Singh Gill, D.; Linch, D. C.; Trneny, M.; Bosly, A.; Milpied, N. J.; Radford, J.; Ketterer, N.; Shpilberg, O.; Duhrsen, U.; Hagberg, H.; Ma, D. D.; Viardot, A.; Lowenthal, R.; Briere, J.; Salles, G.; Moskowitz, C. H.; Glass, B.

Book ID
118026280
Publisher
American Society of Clinical Oncology
Year
2012
Tongue
English
Weight
218 KB
Volume
30
Category
Article
ISSN
0732-183X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Therapeutic results in patients with rel
Therapeutic results in patients with relapsed diffuse large B cell Non-Hodgkin's lymphoma achieving complete response only after autologous stem cell transplantation
✍ Felicetto Ferrara; Assunta Viola; Carolina Copia; Ettore Mariano Schiavone; Mari πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 92 KB

## Abstract Forty patients with relapsed diffuse large B cell lymphoma (DLBCL) autografted in partial response (PR) (__n__ = 23) or in refractory relapse (RR) (__n__ = 17) achieved complete remission (CR) after autologous stem cell transplantation (ASCT). Salvage treatment consisted of ifosphamide,